Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Rezolute Inc (RZLT)

Rezolute Inc (RZLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 215,505
  • Shares Outstanding, K 60,535
  • Annual Sales, $ 0 K
  • Annual Income, $ -68,460 K
  • EBIT $ -73 M
  • EBITDA $ -76 M
  • 60-Month Beta 1.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.14

Options Overview Details

View History
  • Implied Volatility 309.94% ( -61.13%)
  • Historical Volatility 104.47%
  • IV Percentile 90%
  • IV Rank 23.77%
  • IV High 1,264.34% on 04/04/25
  • IV Low 12.39% on 09/24/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 559
  • Volume Avg (30-Day) 598
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 11,987
  • Open Int (30-Day) 10,589

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.25
  • Number of Estimates 3
  • High Estimate -0.22
  • Low Estimate -0.30
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +43.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.39 +48.95%
on 04/16/25
4.29 -17.02%
on 04/23/25
+0.94 (+35.88%)
since 04/15/25
3-Month
2.21 +61.09%
on 04/07/25
4.80 -25.83%
on 02/18/25
-1.05 (-22.78%)
since 02/14/25
52-Week
2.21 +61.09%
on 04/07/25
6.19 -42.45%
on 11/11/24
+0.91 (+34.34%)
since 05/15/24

Most Recent Stories

More News
Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update

RZLT : 3.56 (+2.01%)
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

RZLT : 3.56 (+2.01%)
Rezolute to Participate in Upcoming Investor Conferences

RZLT : 3.56 (+2.01%)
Rezolute, Inc. Announces Closing of Underwritten Offering

RZLT : 3.56 (+2.01%)
Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

RZLT : 3.56 (+2.01%)
Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”)

RZLT : 3.56 (+2.01%)
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors

RZLT : 3.56 (+2.01%)
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

RZLT : 3.56 (+2.01%)
Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

RZLT : 3.56 (+2.01%)
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference

RZLT : 3.56 (+2.01%)

Business Summary

Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United...

See More

Key Turning Points

3rd Resistance Point 3.90
2nd Resistance Point 3.73
1st Resistance Point 3.65
Last Price 3.56
1st Support Level 3.40
2nd Support Level 3.23
3rd Support Level 3.15

See More

52-Week High 6.19
Fibonacci 61.8% 4.67
Fibonacci 50% 4.20
Fibonacci 38.2% 3.73
Last Price 3.56
52-Week Low 2.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar